The cultivation of plants for the creation of medicines requires a higher level of standardisation and quality control than those used for food, or wellness products.
It is essential that all potential contaminants from the environment be strictly controlled for to ensure that the end product is of the highest quality. In addition to this, the factors which control the development of the active pharmaceutical ingredients within the plants must be monitored and adjusted to standardise their production.
Glass Pharms uses the most cutting edge technologies in glasshouse protected horticulture to optimise for purity and consistency. Until recently, controlling all of the variables necessary to make this a reality was almost impossible. Now, with the aid of AI, remote sensors, monitoring and automation techniques, Glass Pharms is able to replicate growing results to new standards of reliability.
From sourcing precision chemotypes that have proven efficacy, through to state-of-the-art testing for viruses fungi and mould, every step along the way is calculated to produced a highly standardised crop that the manufacturers of plant-based medicines can rely upon.
If you are a UK-based clinic, pharmaceutical company or research institution, please contact us to discuss your exact needs and requirements.
Different plant-based medicines require different genetics. Glass Pharms has a substantial library of precision genetics that customers can choose from to ensure a profile that best matches the API's they are looking for.
All of the genetics we use are guaranteed disease-free and our standardisation processes mean that the chemotypes that you order will be consistent across the batch to industry leading standards. We are happy to consult with clients on the options that might best suit the needs of their patients.
Our goal is to take the guess work out of the equation when it comes to choosing the optimal cultivars for your products.